Neuron-Specific Gene Family Member 1 is a Potential New Therapeutic Target Associated with Immune Cell Infiltration for Breast Cancer

  • 0Department of Breast Surgery, Affiliated Hospital of Hebei Engineering University, Handan, Hebei, 056000, People's Republic of China.

|

|

Summary

This summary is machine-generated.

Neuron-specific gene family member 1 (NSG1) is highly expressed in early breast cancer (BC) and indicates a good prognosis. NSG1 influences the BC immune microenvironment, suggesting it may be a therapeutic target.

Area Of Science

  • Oncology
  • Molecular Biology
  • Immunology

Background

  • Breast cancer (BC) is a heterogeneous disease with unclear roles for specific genes.
  • Neuron-specific gene family member 1 (NSG1), a transmembrane protein, has been observed in various tumors.
  • The specific function and prognostic significance of NSG1 in BC remain largely unexplored.

Purpose Of The Study

  • To investigate the role of NSG1 in breast cancer (BC) pathogenesis and progression.
  • To evaluate NSG1 as a potential prognostic biomarker for BC patients.
  • To explore the association of NSG1 with the BC immune microenvironment.

Main Methods

  • Analysis of NSG1 mRNA expression and prognostic value using The Cancer Genome Atlas and Gene Expression Omnibus databases.
  • Construction of a clinical risk model based on NSG1 expression.
  • Immunohistochemical analysis of NSG1 protein in a cohort of 192 BC patients.
  • Enrichment analysis to predict NSG1's biological functions.
  • Single-cell analysis to assess NSG1's correlation with the BC immune microenvironment.
  • Kaplan-Meier and Cox regression analyses for prognosis and clinicopathological correlations.

Main Results

  • Neuron-specific gene family member 1 (NSG1) exhibits high expression in early-stage breast cancer (BC).
  • Elevated NSG1 expression correlates with a favorable prognosis in BC patients.
  • NSG1 is implicated in the T-cell receptor complex and associated with CD8 T cells within the BC immune microenvironment.
  • NSG1 may promote M1 polarization of macrophages.

Conclusions

  • Neuron-specific gene family member 1 (NSG1) serves as a promising biomarker for good prognosis in breast cancer (BC).
  • NSG1's association with the BC immune microenvironment highlights its potential as a therapeutic target.
  • Further research into NSG1 could lead to novel treatment strategies for BC.

Related Concept Videos

Targeted Cancer Therapies 02:57

7.5K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle 02:38

6.4K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

lncRNA - Long Non-coding RNAs 02:39

8.5K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Enzyme-linked Receptors 01:00

77.3K

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...